NBE-Therapeutics AG - Ownership and Business Overview

Life ScienceCompany

NBE-Therapeutics AG Ownership

Who owns NBE-Therapeutics AG?

NBE-Therapeutics AG is owned by Boehringer Ingelheim. It was acquired on December 10, 2020.

NBE-Therapeutics AG Business Overview

Where is NBE-Therapeutics AG headquartered?

NBE-Therapeutics AG is headquartered in Basel, Switzerland.

What sector is NBE-Therapeutics AG in?

NBE-Therapeutics AG is a life science company.

When was NBE-Therapeutics AG founded?

NBE-Therapeutics AG was founded in 2012.

Life Science M&A Summary in 2020

Out of 60 sectors in the Mergr database, life science ranked 6 in number of deals in 2020. The largest life science acquisition in 2020 was Alexion Pharmaceuticals - which was acquired by AstraZeneca for $39.0B.

Join Mergr to view all 282 acquisitions of life science companies in 2020, including 23 acquisitions by private equity firms, and 259 by strategics.

NBE-Therapeutics AG

Technology Park Basel, Hochbergstrasse 60C,
Basel, CH-4057
Switzerland,
+41 61 633 22 30
www.nbe-therapeutics.com

NBE-Therapeutics is a privately-owned Swiss biotech company based in Basel and founded in 2012 with the vision of developing next-generation immune-stimulatory antibody-drug conjugate (iADC) products. NBE-Therapeutics advances its products to clinical proof of concept with the goal of improving treatment options for cancer patients. The company leverages proprietary platforms covering all aspects of ADC development: its Transpo-mAb Display technology for antibody discovery, its SMAC-Technology for site-specific payload conjugation of toxins to antibodies, and a novel highly effective and immune-stimulatory anthracycline-based toxin platform.


 Subscribe to unlock this and 201,649
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for NBE-Therapeutics AG

Life Science Companies , Switzerland Companies